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http://www.biomedcentral.com/1471-2490/14/52RESEARCH ARTICLE Open AccessComparison of the simplified International Index
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Zhengyan Tang1†, Dongjie Li2†, Xiaobo Zhang2, Lu Yi3, Xiangsheng Zhu4, Xiangyang Zeng5 and Yuxin Tang6*Abstract
Background: The simplified International Index of Erectile Function (IIEF-5) is a convenient, reliable and validated
diagnostic tool for erectile dysfunction (ED). However, few studies focused on IIEF-5 in ED patients with different
pathophysiological causes. ,We aim to compare the IIEF-5 score among ED patients with specific pathophysiologies
in this study.
Methods: The IIEF-5 score of 3,327 ED patients (median age 39 years) was analyzed. The primary causes of ED were
determined by comprehensive diagnostic procedures in the urology/andrology clinics in five training hospitals.
Patients with uncertain pathophysiologic cause were excluded.
Results: 176 patients were excluded, 3151 patients with ED history between 0.5 year and 20 years, were enrolled. The
causes of ED was classified as psychogenic (59.2%), vasoculogenic (21.3%), neurogenic (4.1%), anatomical/structural
(2.8%), hormonal (7.1%) or drug-induced (5.5%). A significant difference was detected in the median IIEF-5 score
between psychogenic ED and organic ED (15 (IQR 13, 17) versus 12 (IQR 9.5, 14.5), P < 0.001). There was no significant
difference of IIEF-5 scores among the organic groups (P = 0.073), or between arteriogenic and venogenic groups
(13 (IQR 10.5, 15.5) versus 13 (IQR 11–15), P = 0.912 (adjusted α = 0.017)). However, the median IIEF-5 score of those
with a mixed vascular cause was the lowest among vasculogenic patients (11 (IQR 8.5-13.5), scores for the three groups:
P = 0.003.).
Conclusions: The IIEF-5 scores of men with psychological ED are higher than those with organic causes, but there is
no difference among patients with different organic pathophysiologies. Our data indicate that IIEF-5 is not a definitive
diagnostic tool to discriminate the pathophysiological causes of ED.
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Erectile dysfunction (ED) is defined as the inability to
achieve and maintain an erection sufficient to permit
satisfactory sexual intercourse [1,2]. A high prevalence of
ED has been reported in many studies, and the situation
could be even worse in the coming years, particularly
in developing countries [3,4]. Although the release of
phosphodiesterase type 5 inhibitors (PDE5-i) highly
improved the treatment of ED patients with almost all
kinds of pathophysiological causes, the high discontinuation* Correspondence: mmcct@126.com
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reproduction in any medium, provided the orrate of PDE5 inhibitors make it still essential to seek the
causes for disease diagnosis and treatment [2,5-7].
The pathophysiology of ED includes vasculogenic, neuro-
genic, hormonal, anatomical, drug-induced and psychogenic
causes in nature [8]. Identifying the pathophysiology of ED
can significantly help to assess the modifiable risk factors
and other medical conditions [9,10]. Furthermore, assessing
the causes of ED is essential to cure patients with some
certain types of ED [11].
The International Index of Erectile Function (IIEF) and
the simplified International Index of Erectile Function
(IIEF-5) are widely used, validated, self-administered
questionnaires, and havebeen demonstrated to be high
degree of sensitivity and specificity to ED [12-14]. Serkand. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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evaluate the ability of the IIEF differentiating different
pathophysiologies of ED [15]. However, they concluded
that the IIEF is not completely accurate in differentiating
between organic and psychogenic ED. In addition, several
studies [16-18] have confirmed that there is no significant
difference in the IIEF or IIEF-5 scores among patients
with specific vascular causes (i.e. arterial insufficiency,
vascular leakage and mixed disorder).
However, few investigations about the differences in
IIEF-5 among patients with all different pathophysiology
have been reported. It is still unclear whether the IIEF-5
is capable of diagnosing the cause of ED. The present
study aimed to evaluate the ability of the IIEF-5 to
differentiate among all different pathophysiology of
ED, according to standard comprehensive diagnostic
procedures [8,19].
Methods
We investigated consecutive patients with established
ED in the urology or andrology clinics from three
university affiliated hospitals (Xiangya Hospital, the
Second Xiangya Hospital, and the Third Xiangya
Hospital, Central South University) and two training
hospitals (the First People’s Hospital of Chenzhou, the
Central Hospital of Xiangtan) from January 2006 to
January 2010. All subjects provided written informed
consent. The project was organized by the Third Xiangya
hospital, Central South University, and it was approved by
the ethics committee of each institution. All protocols
were reviewed and approved by the ethics committee of
the Third Xiangya hospital, Central South University.
All patients (n = 3327) complained of the inability to
achieve and/or maintain erection of sufficient rigidity
and duration to permit satisfactory sexual performance.
The patients completed the IIEF-5 at doctor’s office.
Then they underwent independent evaluations by an
experienced urologist or andrologist. The diagnostic
steps and classification were based on EAU guidelines
on erectile dysfunction (update March 2005) [8]. A
detailed medical and sexual history was obtained and a
physical examination was performed in all patients. Physical
examination included the assessment of genitourinary,
endocrine, vascular, and neurologic systems. A fasting
glucose and lipid profile screen was performed if not
assessed in the previous 12 months. Further laboratory
testing included a morning sample of total testosterone
and additional tests were determined when relevant
cause was suspected. Patients with abnormal responses to
examinations or tests were referred for specific tests
(e.g. nocturnal penile tumescence and rigidity, NTPR).
The most primary cause was judged on the basis of the
above-mentioned comprehensive diagnostic procedures.
For example, they could be diagnosed as hormonal ED,when the patients with low sexual desire, abnormal
physical examination (e.g. small testes, reduced body
hair, gynecomastia), low testosterone level, or other
related hormone abnormalities (e.g. LH, E2, PRL,
TSH, T3, T4). A patient will be diagnosed as psychogenic
ED if no organic cause was detected, whereas he was
suffered with mental disorders including performance
anxiety, a strained relationship, psychological stress, lack
of sexual arousability, and overt psychiatric disorders such
as depression and schizophrenia (see Additional file 1).
176 subjects were excluded from this study due to the
following reasons: (1) cause could not be determined by
above procedures; (2) patients had two or more causes
that are equally predominant; (3) patients were not
willing to accept further investigations.
The severity of ED was evaluated using IIEF-5, and
was classified into 4 levels based on the scores: severe
(5–7), moderate (8–11), mild to moderate (12–16), and
mild (17–21) [13].
Statistical analysis
Qualitative variables were described by frequency,
percentages, mean, and 95% confidence intervals.
Nonparametric test was utilized: (1) Spearman correlations
were used to assess the association between individual
variables; (2) quantitative data of two individual samples
were evaluated by Wilcoxon rank sum test; (3) multiple
samples were evaluated by Kruskal-Wallis H test.
Comparison between categorical variables was performed
using chi-square test. Data analysis was performed
using the SPSS 17.0 software (SPSS, Chicago, USA).
The significance level was set at P = 0.05, and it was
adjusted to 0.017 (0.05/3 = 0.017) for pairwise comparisons
among the three vasculogenic subgroups (arteriogenic,
venogenic, mixed vascular).
Results
The median age of the enrolled subjects (n = 3,151) was
39 (interquartile range, 29.5-48.5) years, with a range from
19 to 70 years.
The primary causes of ED were psychogenic (1866
patients, 59.2%) and organic (1285 patients, 40.8%)
respectively. The pathophysiological causes of organic
ED were vasculogenic (52.1%, 670/1285), neurogenic
(10.0%, 129/1285), anatomical/structural (6.9%, 89/1285),
hormonal (17.4%, 224/1285), and drug-induced (13.5%,
173/1285), respectively.
The IIEF-5 scores of patients with different primary
causes were presented in Figure 1. The median IIEF-5
score of these subjects was 14 (interquartile range,
11.5, 16.5). A significant difference in the mean IIEF-5
score was observed between the subjects with psychogenic
ED and those with organic ED (P = 0.000) (Table 1).
Moreover, although there was a significant difference
Figure 1 The IIEF-5 scores of 3,151 patients with different
pathophysiologic causes. Error bar: interquartile range. Kruskal-Wallis
H test for all groups, all organic groups (except for psychogenic):
P = 0.000, and P = 0.073, respectively.
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significant difference was identified in patients with
organic causes (P = 0.073).
The distribution of ED severity in different pathophysio-
logic causes was presented in Table 2. Moreover, as
indicated in Figure 2, the ED severity increased with
age. A significant correlation was found between age
and IIEF score.
The severity and age distribution of patients with
various vasculogenic ED was shown in Table 3 and
Table 4 , respectively. A significant difference was detected
among the different vascular causes, the ED severity of
patients with mixed vascular was higher than those with
either arteriogenic or venogenic cause, but no difference
was found between arteriogenic and venogenic causes
(13 vs 13, P = 0.912 (adjusted α = 0.017)).
Patients’ median duration of ED was 2 years (interquartile
range, 0.5-3.5). There were significant differences in
the duration among patients from each pathophysiology
(Kruskal-Wallis H test for all groups, all groups (exceptTable 1 Age distribution and median IIEF-5 scores of
patients with different primary pathophysiologic causes
Primary causes <40 year ≥40 year Overall Median
IIEF (IQR)
Psychogenic 1145 (66.4) 721 (50.6) 1866 (59.2) 15 (13, 17)
Organic 580 (33.6) 705 (49.4) 1285 (40.8) 12 (9.5, 14.5)
Total 1725 1426 3151 14 (11.5, 16.5)
IQR, interquartile range. Data in parentheses are percentages of different age,
unless otherwise noted.
Age: χ2 test for psychogenic versus organic: Pearson Chi-square = 80.858, P < 0.001.
IIEF-5: Wilcoxon rank sum test for psychogenic versus organic: P < 0.001.for psychogenic), all organic groups (except for psycho-
genic and unknown): P = 0.000, P = 0.000, and P = 0.000,
respectively). Meanwhile, the IIEF-5 score was nega-
tively correlated with ED duration (rs = −0.189, P = 0.000,
Spearman correlations). Furthermore, a significant dif-
ference in duration was detected among patients with
three vascular causes (P = 0.046), but no significant
difference in duration was found among arbitrary vascular
causes (arteriogenic versus venogenic, arteriogenic versus
mixed, venogenic versus mixed, P = 0.538, 0.019, and
0.027 respectively (adjusted α = 0.017).
Discussion
ED is a serious and growing public health problem. The
prevalence of ED increased with age [20]. In most countries,
a large proportion of patients visiting outpatient clinics were
older than 40 years [21,22]. However, our results indicated
that the number of young (<40 years) ED patients were
more than ones over 40 years (Table 1). Similar results were
also obtained in several studies of Chinese ED patients
[23,24]. In a 5-year survey in 11 cities in China, Liu et al.
found that most patients were younger than 50 years old
(75.7% in 2003 and 74.5% in 2008) [23]. Another study in
older (>40 years) patients in Beijing also showed that only
27.4% of them recognized ED as a disease, and just 12.1%
visited their doctors [24]. These were likely associated with
more conservative culture in China [10,25].
ED has serious effects on men’s physical and mental
health [26,27]. According to different pathogenic mecha-
nisms, ED has usually been classified as psychogenic,
organic (ie, neurogenic, hormonal, vasculogenic, anatomic/
structural, or drug-induced), or mixed psychogenic and
organic causes [8,28]. If ED is longstanding, this may build
patient’s own world of fear, anxiety, worry, depression and
distress around his disorder [29,30]. Hence, the mixed
form is generally regarded as the most common category
in most studies [2,31]. In this study, we also found that
nearly half of subjects have combined different causes.
Their combined causes are not necessarily the same with
each other. Hence, it is not conducive to analyze the ED
causes if this large number of patients all just classified as
“the mixed form”. Therefore, the primary causes of sub-
jects were studied in this investigation to avoid confusion
in patients with mixed causes. The primary cause was
determined by an experienced urologist or andrologist
according to the comprehensive diagnostic procedures
(for details see Methods and Additional file 1). It has
been confirmed that the comprehensive procedures are
superior in establishing the causes of ED [19,32]. Under
some circumstances doctors could not draw a clear distinc-
tion between the primary cause and the minor cause.
These cases (176/3327, 5.3%) were excluded from present
investigation. This proportion was similar to a study by
Hatzichristou et al. (78/1276, 6.1%) [19].
Table 2 Patient severity and primary pathophysiologic cause erectile dysfunction
Cause Severe Moderate Mild to moderate Mild OR (95% CI) P Value
Psychogenic 17 (0.9) 356 (19.1) 859 (46.0) 634 (34.0) 1.00 (reference)
Vasculogenic 83 (12.4) 225 (33.6) 281 (41.9) 81 (12.1) 1.29 (1.19-1.38) 0.000
Neurogenic 17 (13.2) 45 (34.9) 54 (41.9) 13 (10.1) 1.27 (1.17-1.39) 0.000
Anatomical/structural 8 (9.0) 26 (29.2) 42 (47.2) 13 (14.6) 1.25 (1.15-1.37) 0.000
Hormonal 17 (7.6) 111 (49.6) 81 (36.2) 15 (6.7) 1.23 (1.14-1.34) 0.000
Drug-induced 15 (8.7) 70 (40.5) 74 (42.8) 14 (8.1) 1.30 (1.19-1.41) 0.000
Overall 157 (5.0) 833 (26.4) 1391 (44.1) 770 (24.4)
OR, odds ratio; CI, confidence interval. Data in parentheses are percentages, unless otherwise noted. Adjusted OR (for age) was measured by the ratio of sicker
patients (severe and moderate, IIEF-5 scores of which are between 5 and 11, versus mild to moderate and mild, IIEF-5 scores of which are between 12 and 21 ) in
every groups. The psychological ED group (IIEF-5 (5–11) / IIEF-5 (12–21)) was put as reference. CI, confidence interval.
Table 3 Comparison of the severity of patients with
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administered tool to assess erectile function [13,33].
Rosen RC, et al. believed that there are still many potential
areas for future research on the IIEF [34]. For example,
the IIEF may not be completely accurate in differentiating
among various sub-groups [34,35].
The aim of this study was to assess the difference
among all the different pathophysiologies of ED in IIEF-5
by analysing a multicenter, large sample of ED patients
using the comprehensive procedures. Previous studies
have compared the IIEF or IIEF-5 between organic and
psychogenic ED, or between arteriogenic and cavernosal
ED. Serkan Deveci et al. compared the IIEF scores with
the results of flow dynamics analysis, using the penile
duplex Doppler ultrasonography (DUS) in 112 patients.
They found that the IIEF was not completely accurate in
differentiating between organic and psychogenic ED, but
have potential ramifications for evaluating the baseline
severity of ED in trials of erectogenic agents. All patients
with venogenic cause (4/4) were all categorized as severe
ED according to IIEF score, and none of the patients
(0/16) with venous leak (including venogenic cause
and mixed vascular cause) had mild ED. However,
more than a fifth (6/28) of the men with normal
erectile haemodynamics also were classified as severe
ED [15]. Melman A, et al. used the Rigiscan results
to assess the ability of the IIEF-6 in 32 consecutiveFigure 2 Severity of ED increased with age. Spearman correlations
for 3151 patients: rs = −0.198, P = 0.000.patients. Similarly, no significant correlation was
found between NPTR data and IIEF-6 score. They
concluded that the IIEF-6 is unable to differentiate
between various causes of ED [35].
In addition, several studies [16-18] also suggestted that
there is no significant difference in the IIEF or IIEF-5
scores among patients with specific vascular causes
(i.e. arterial insufficiency, vascular leakage and mixed
disorder). Our data indicated that not only there is
no significant difference between arteriogenic and
venogenic cause in IIEF-5, but also these causes have
a similar severity distribution (Table 3). Hence, all
these results conducted that IIEF-5 is not accurate in
distinguishing the specific causes of vasculogenic ED.
Further, in the current study, although we found a
statistical difference among all different pathophysiologies
in IIEF-5 (P = 0.000), no significant difference were found
among all kinds of organic causes (P = 0.067 or P = 0.073
(except for unknown)) (Figure 1). Hence, the main
difference in IIEF-5 was between psychogenic and all other
causes. So the IIEF-5 did not statistically differentiate
the specific organic causes of ED as determined by
evidence-based testing by the comprehensive diagnostic
procedures, but it had potential ramifications for the evalu-
ation of whether the patients were psychological origin.different vascular causes according to IIEF-5
Vascular
cause n (%)




Arteriogenic 34 (12.9) 80 (30.4) 115 (43.7) 34 (12.9) 13 (10.5, 15.5)
Venogenic 34 (10.5) 106 (32.8) 141 (43.7) 42 (13.0) 13 (11–15)
Mixed
vascular
15 (17.9) 39 (46.4) 25 (29.8) 5 (6.0) 11 (8.5-13.5)
Overall 83 (12.4) 225 (33.6) 254 (41.9) 85 (12.1) 13 (11, 15)
IQR, interquartile range. Data in parentheses are percentages, unless otherwise
noted. Severity distribution: χ2 test for all groups, all groups (except for mixed
vascular): Pearson Chi-square = 14.351, P = 0.026; Pearson Chi-square = 0.984,
P = 0.805 (adjusted α = 0.017), respectively. IIEF-5: Kruskal-Wallis H test for all
groups: P = 0.003. Wilcoxon rank sum test for arteriogenic versus venogenic:
P = 0.912 (adjusted α = 0.017).
Table 4 Age and specific causes of vasculogenic ED
Vascular cause n (%) 19-29 30-39 40-49 50-59 60-70 Median age (IQR)
Arteriogenic 63 (24.0) 43 (16.3) 114 (43.3) 35 (13.3) 8 (3.0) 40 (32, 48)
Venogenic 81 (25.1) 94 (29.1) 108 (33.4) 34 (10.5) 6 (1.9) 39 (31.5-46.5)
Mixed vascular 11 (13.1) 22 (26.2) 32 (38.1) 16 (19.0) 3 (3.6) 41 (35–47)
Overall 155 (23.1) 159 (23.7) 254 (37.9) 85 (12.7) 17 (2.5) 40 (32.5, 47.5)
IQR, interquartile range. Data in parentheses are percentages, unless otherwise noted. Age distribution: χ2 test for all groups, all groups (except for mixed
vascular): Pearson Chi-square = 30.416, P = 0.000; Pearson Chi-square = 19.24, P = 0.001 (adjusted α = 0.017), respectively. Age: Kruskal-Wallis H test for all groups:
P = 0.003. Wilcoxon rank sum test for arteriogenic versus venogenic: P = 0.04 (adjusted α = 0.017).
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population based. However, the patients seeking treatment
at clinics were not chosen on purpose. Rather, they were
consecutive patients who were diagnosed with erectile
dysfunction by urologist/andrologist. Although these
results could not represent the epidemiological character-
istics in ED population, it could be more useful for clinical
urologists/andrologists. Secondly, all information was re-
corded by the physicians, thus, self-reported questionnaire
(except for IIEF-5) for patients is lacking. This could have
resulted in information loss, particularly regarding the
demographic characteristics. Thirdly, the contribution of
the relational factors (e.g. the types of drugs that can in-
duce ED) in patients were less evaluated, which should be
enhanced in follow-up. Finally, an objective, quantitative
criteria for judging primary pathophysiology are lacking.
Hence, the identification of primary pathophysiological
cause depends in part on the physician’s judgment, which
means inevitable subjectivity. However, this subjective bias
could be reduced by basing the identification on uniform
guidelines in the diagnostic procedures. We also plan to
use statistical methods (e.g. discriminant analysis) to
narrow this bias in further research.
Conclusions
This multicenter study was conducted in a large sample
of ED patients seeking treatment at clinics. It indicated
that the age of Chinese outpatients with ED was younger
than other countries. Moreover, no significant difference in
IIEF-5 scores was observed among ED patients with differ-
ent organic pathophysiologies. Therefore, IIEF-5 was not
completely sufficient to distinguish the ED pathophysiology,
and it should be used with caution.
Additional file
Additional file 1: Self-developed diagnostic criteria for primary
pathophysiological cause of ED (based on EAU guidelines on
erectile dysfunction 8).
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